Company Filing History:
Years Active: 2022-2025
Title: Aurélie Mathieu: A Pioneer in Phage-derived Innovations
Introduction
Aurélie Mathieu, an innovative inventor based in Paris, France, has made significant strides in the field of biotechnology. With seven patents to his name, Mathieu focuses on the development of phage-derived particles for the precise delivery of DNA payloads, pushing the boundaries of genetic engineering and therapeutic applications.
Latest Patents
Mathieu's latest inventions include groundbreaking patents related to phage-derived particles aimed at enhancing in situ DNA delivery. One of his prominent inventions pertains to carrying DNA vectors with a phage packaging signal and a gene of interest. This innovation involves producer cells that harbor DNA vectors equipped with a phage packaging signal, enabling the effective production of phage-derived particles capable of robustly transducing recipient cells, thus facilitating transgene expression.
Another significant patent focuses on the production bacterial cells tailored for generating phage particles or phage-derived delivery vehicles. These production bacterial cells are stably engineered to include at least one phage structural gene and at least one phage DNA packaging gene, all derived from a specific type of bacteriophage. This invention enhances the scalability and efficiency of phage-based therapeutic methods.
Career Highlights
Aurélie Mathieu is affiliated with Eligo Bioscience, a pioneering company in the realm of biotechnology. His work continues to contribute to the advancement of genetic engineering, particularly in the development of innovative solutions for gene therapy and delivery systems.
Collaborations
During his career, Mathieu has collaborated with esteemed coworkers Antoine Decrulle and Aymeric Leveau. These partnerships are instrumental in fostering innovation and enhancing the research capabilities within the company, allowing for comprehensive exploration and development of cutting-edge biotechnological advancements.
Conclusion
In summary, Aurélie Mathieu stands out as a leading inventor in the biotechnology sector, specifically for his contributions to phage-derived technologies. With a strong focus on delivering DNA payloads and enhancing gene therapy potential, his work at Eligo Bioscience is paving the way for future innovations in this critical field. His patents not only reflect his ingenuity but also symbolize the collaborative spirit that drives progress in scientific research and development.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.